Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
View Patent ↗The present invention is directed to reagents useful for generating immune responses to Mycobacterium tuberculosis and for diagnosing infection and disease in a subject that has been exposed to M. tuberculosis.
1. A diagnostic composition that discriminates between infection by Mycobacterium tuberculosis and vaccination by Bacille Calmette Guerin (BCG) strain of Mycobacterium bovis , said composition comprising antigens, all antigens in said composition consisting of at least three different polypeptides of the Mycobacterium tuberculosis complex that are not encoded by BCG, and said polypeptides including at least one isolated polypeptide from the group consisting of (i) a first amino acid sequence consisting of the sequence of MTBN4 (SEQ ID NO: 4), (ii) a second amino acid sequence that is an antigenic segment of MTBN4 that has Mycobacterium tuberculosis specific antigenic or immunogenic properties and (iii) a third amino acid sequence that is identical to said first or second amino acid sequence but has conservative substitutions and has Mycobacterium tuberculosis specific antigenic or immunogenic properties.
2. The composition of claim 1 , wherein said at least one isolated polypeptide comprises consists of said first or second amino acid sequence.
3. The composition of claim 2 further including a pharmaceutically acceptable diluent or filler.
4. The composition of claim 1 further including a pharmaceutically acceptable diluent or filler.
5. A mixture of a composition of claim 1 and a bodily fluid.
6. The mixture of claim 5 , wherein the bodily fluid is blood, saliva, plasma, serum, urine, semen, or a lavage.
7. The composition mixture of claim 6 , wherein the lavage is a bronchoalveolar lavage, a vaginal lavage, or lower gastrointestinal lavage.